CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

The Harvard Drug Group LLC recalls Gabapentin Capsules

Read the official FDA notice

Published
9 Jul 2025
Units affected
2 products
Agency
FDA
Country
United States

The hazard

Defective container; blister packaging inadequately sealed.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN, 46268 USA, NDC 0904-6665-61

Gabapentin Capsules, USP, 100 mg, 10 capsules (10x1) per bag, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN, 46268 USA, Distributed by Cardinal Health, Dublin, OH 43017, NDC 55154-3363-0

Brand / company
The Harvard Drug Group LLC
Codes / lots
Lot# M05205, Exp Date 10/2026 | Lot# M05205A and M05205B, Exp Date 10/2026.
Distribution
Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 9 Jul 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.